Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 4/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | GFER | P55789 | 1/20 | 0.50 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.48 |
| ▸ | MAOB | P27338 | 4/20 | 0.42 |
| ▸ | MAOA | P21397 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | FDPS | P14324 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12026106 | 0.86 | MIF (0.33) | CYP3A4ALDH1A1TSHRLMNA | |
| SCHEMBL11296929 | 0.79 | HRH3 (0.50) | LOXL2MAPTCA12CA1CA2 | |
| SCHEMBL18868423 | 0.78 | ALDH1A1 (0.55) | CYP3A4TDP1ALDH1A1TSHRGFER | |
| SCHEMBL12630868 | 0.77 | PRSS1 (0.57) | CYP3A4TSHRMAOAKMT2ALMNA | |
| SCHEMBL24667496 | 0.75 | GFER (0.59) | CYP3A4TDP1ALDH1A1TSHRGFER | |
| SCHEMBL12463807 | 0.74 | MIF (0.52) | LOXL2MAOBSMN1; SMN2LMNA | |
| SCHEMBL15308709 | 0.74 | — | — | |
| SCHEMBL16503463 | 0.74 | CYP1A2 (0.43) | CYP3A4 | |
| SCHEMBL13793209 | 0.74 | IDO1 (0.46) | TDP1MAPTSMN1; SMN2TP53CA1 | |
| SCHEMBL18292655 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0572720-B1 | A process for preparing thermoplastic resin compositions with excellent hydrochlorofluorocarbon resistance | LUCKY LTD (KR) | 1997-04-16 | — | — | EP | claimed |
| US-5283287-A | Graft polymer containing polymerization inhibitor | LUCKY LIMITED (KR) | 1994-02-01 | — | — | US | claimed |
| EP-0572720-A2 | A process for preparing thermoplastic resin compositions with excellent hydrochlorofluorocarbon resistance | LUCKY, LTD. (KR) | 1993-12-08 | — | — | EP | claimed |
| CN-117769759-A | Electronic device and method of manufacturing the same | 富士胶片株式会社 | 2024-03-26 | — | — | CN | disclosed |
| CN-117652208-A | Electronic device and method of manufacturing the same | 富士胶片株式会社 | 2024-03-05 | — | — | CN | disclosed |
| CN-116139830-B | Micromolecular oximation natural biomass for uranium adsorption and preparation method thereof | 海南大学 | 2023-08-15 | — | — | CN | disclosed |
| CN-116139830-A | Micromolecular oximation natural biomass for uranium adsorption and preparation method thereof | 海南大学 | 2023-05-23 | — | — | CN | disclosed |
| US-10196344-B2 | Glaucocalyxin a derivative and preparation method and application thereof | SUZHOU PHARMAVAN CANCER RESEARCH CENTER CO., LTD. (CN) | 2019-02-05 | — | — | US | disclosed |
| US-20180079711-A1 | GLAUCOCALYXIN A DERIVATIVE AND PREPARATION METHOD AND APPLICATION THEREOF | SUZHOU PHARMAVAN CO., LTD (CN) | 2018-03-22 | — | — | US | disclosed |
| EP-1773786-B1 | FIVE-MEMBERED HETEROCYCLES USEFUL AS SERINE PROTEASE INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2017-04-26 | — | — | EP | disclosed |
| WO-2010102043-A1 | PROCESS FOR PREPARING STRUCTURED ORGANIC FILMS (SOFS) VIA A PRE-SOF | XEROX CORPORATION (US) | 2010-09-10 | — | — | WO | disclosed |
| EP-0572720-B1 | A process for preparing thermoplastic resin compositions with excellent hydrochlorofluorocarbon resistance | LUCKY LTD (KR) | 1997-04-16 | — | — | EP | disclosed |
| US-5283287-A | Graft polymer containing polymerization inhibitor | LUCKY LIMITED (KR) | 1994-02-01 | — | — | US | disclosed |
| EP-0572720-A2 | A process for preparing thermoplastic resin compositions with excellent hydrochlorofluorocarbon resistance | LUCKY, LTD. (KR) | 1993-12-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180079711-A1 | GLAUCOCALYXIN A DERIVATIVE AND PREPARATION METHOD AND APPLICATION THEREOF | SSB, GYPA, PEX14 | CYP3A4 4656/4885TDP1 4217/4885ALDH1A1 4846/4885 |
| US-10196344-B2 | Glaucocalyxin a derivative and preparation method and application thereof | SSB, GYPA, PEX14 | CYP3A4 4656/4885TDP1 4217/4885ALDH1A1 4846/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.